Keytsiia is a real Wegovy® patient and paid spokesperson for Novo Nordisk. Sometimes one photo is all it takes to spark a change. For Keytsiia, a North Carolina school district administrator, a snapshot of her sitting on a motorcycle in 2016 was the wake-up call she needed to start focusing on losing weight.
Keystiia had been an avid rider since 2009, and a trip to the local dealership to browse new bikes was her husband’s attempt to uplift her. It didn’t have the intended effect, but instead, that single photo became the catalyst for a decade of positive momentum. At the time, the mother of two weighed the most she had ever weighed.
She decided to commit fully to the lifestyle approach and stuck with it for more than three years. However, despite making lifestyle changes, Keytsiia wasn’t seeing the results she hoped for and began to question whether her hard work was worth it. I hadn’t lost the weight I had hoped to.” Looking for a different approach, Keytsiia enlisted in a weight-loss program with a nutritionist, who helped her adjust her eating patterns and food choices.
But even with those healthy changes, she wasn’t seeing the progress she hoped for. What finally moved the needle, and helped her lose weight and keep it off, was adding a weight-management medication to her overall healthcare plan of diet and exercise. In January 2023, Keytsiia’s doctor suggested WEGOVY® (semaglutide) injection 2.4 mg.
Wegovy® (semaglutide) injection is a prescription medicine used with a reduced calorie diet and increased physical activity to: Wegovy® (semaglutide) tablets are a prescription medicine used with a reduced-calorie diet and increased physical activity to: Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines. It is not known if Wegovy® injection is safe and effective: It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age. What is the most important information I should know about Wegovy®?Wegovy® may cause serious side effects, including: Wegovy® FlexTouch® pen: Do not share your Wegovy® FlexTouch® pen with other people, even if the needle has been changed.
You may give other people a serious infection or get a serious infection from them. Please see Medication Guide and Prescribing Information, Including Boxed Warning, for Wegovy® at: Novo-pi.com/wegovy.pdf, and see additional Important Safety Information below. In addition, she and her doctor discussed the potential side effects of WEGOVY, which can include nausea, vomiting, diarrhea, and constipation, as well as other conditions.
Extract — continue reading at the source.
